Legislative reports

The Oregon Prescription Drug Affordability Board approved the PDAB Generic Drug Report 2025 for sending to the Oregon Legislature in accordance with ORS 646A.697. The report includes:

• Background
  
• Pricing, market trends, and issues
  
• Shortages and effects on the health care system
  
• Pricing effect on Medicare and Medicaid spending
  
• Market concerns with importation and tariffs
  
• Group purchasing organization and pharmacy benefit manager practices
  
• Overview of PBM-owned generic and biosimilar manufacturing
  
• Conclusion
  

View 2025 Generic Drug Report